Stryker (SYK) Capital Expenditures Growth (3y) (2012 - 2026)
Stryker (SYK) Capital Expenditures Growth (3y) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.90 Bn | 193.29 Bn | 7.27 Bn | -0.66% |
| 2 | Stryker | 129.12 Bn | 125.64 Bn | 4.50 Bn | 9.94% |
| 3 | Medtronic | 119.32 Bn | 110.10 Bn | 6.41 Bn | 8.89% |
| 4 | Boston Scientific | 73.63 Bn | 73.09 Bn | 3.85 Bn | 10.89% |
| 5 | Edwards Lifesciences | 52.14 Bn | 47.89 Bn | 1.35 Bn | 11.78% |
| 6 | Dexcom | 34.48 Bn | 32.54 Bn | 830.00 Mn | 12.81% |
| 7 | GE HealthCare Technologies | 34.06 Bn | 31.95 Bn | 2.18 Bn | 12.62% |
| 8 | Koninklijke Philips | 26.40 Bn | 23.08 Bn | 4.55 Bn | 19.51% |
| 9 | Steris | 23.17 Bn | 22.69 Bn | 684.20 Mn | 9.52% |
| 10 | Zimmer Biomet Holdings | 19.34 Bn | 18.93 Bn | 1.54 Bn | -17.72% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 9.94% |
| Mar 31, 2026 | 8.49% |
| Dec 31, 2025 | 12.54% |
| Sep 30, 2025 | 10.66% |
| Jun 30, 2025 | 8.57% |
| Mar 31, 2025 | 1.11% |
| Dec 31, 2024 | 8.89% |
| Sep 30, 2024 | 9.35% |
| Jun 30, 2024 | 12.77% |
| Mar 31, 2024 | 26.24% |
| Dec 31, 2023 | -4.22% |
| Sep 30, 2023 | 28.96% |
| Jun 30, 2023 | 11.72% |
| Mar 31, 2023 | -3.35% |
| Dec 31, 2022 | -1.88% |
| Sep 30, 2022 | -5.40% |
| Jun 30, 2022 | -4.66% |
| Mar 31, 2022 | -0.83% |
| Dec 31, 2021 | 10.18% |
| Sep 30, 2021 | -2.44% |